OSAKA -- Japanese drugmaker Shionogi is planning to build a plant in the U.S. to produce the antibiotic cefiderocol, Nikkei learned Friday, seeking to switch exports to local production as President Donald Trump plans to impose high tariffs on pharmaceuticals.
Companies
Japan's Shionogi plans US antibiotic plant with eye on Trump tariffs
Drugmaker seeks to begin production at first overseas plant by 2029
Shionogi is seeking to move production of one antibiotic bound for the U.S. market to a new factory there. (Photo by Toshiki Sasazu)
Read Next
Latest on Companies
